National Institute for Health and Care Excellence5h
Thousands of people with a severe dust mite allergy are set to benefit from life-changing treatment
The treatment is recommended for people aged 12 to 65 who have moderate to severe and persistent allergic rhinitis and have been diagnosed through clinical history and a positive test of their house ...
National Institute for Health and Care Excellence1d
In consultation: Guidance and quality standards
Proposed changes to appeal period for technology appraisal and highly specialised technologies appeals Methods / process manual consultation NICE process and methods 16 February 2025 Spesolimab for ...
National Institute for Health and Care Excellence2d
Harnessing expertise to improve patient access to innovative health technologies
New and innovative mechanisms of action are constantly being discovered and developed into medicines that tackle a broad ...
National Institute for Health and Care Excellence1d
Chemotherapy dose standardisation: NICE position statement
NICE has been collaborating with NHS England on the Chemotherapy Dose Standardisation initiative which has been developed by the Medicines Optimisation and Chemotherapy Clinical Reference Groups (CRGs ...
National Institute for Health and Care Excellence2d
NICE recommends healthcare professionals ask people about gambling at health checks and GP appointments
Healthcare professionals should consider asking people about gambling when speaking to them about smoking and alcohol consumption during a health check or GP appointment, new guidance recommends.
National Institute for Health and Care Excellence12d
International collaboration provides new guidance on the use of surrogate endpoints in cost-effectiveness analysis
NICE, in collaboration with other international health technology assessment agencies, has published a new report which ...
National Institute for Health and Care Excellence7d
Vadadustat for treating symptomatic anaemia in adults having dialysis for chronic kidney disease
There is a simple discount patient access scheme for vadadustat. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS organisations can contact enquiries@medice ...
National Institute for Health and Care Excellence14d
Vamorolone for treating Duchenne muscular dystrophy in people 4 years and over
There is a simple discount patient access scheme for vamorolone. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS organisations can contact ...
National Institute for Health and Care Excellence7d
Vadadustat for treating symptomatic anaemia in adults having dialysis for chronic kidney disease
The evaluation committee considered evidence submitted by MEDICE, a review of this submission by the external assessment group (EAG), and responses from stakeholders. See the committee papers for full ...
National Institute for Health and Care Excellence7d
Vadadustat for treating symptomatic anaemia in adults having dialysis for chronic kidney disease
The 4 technology appraisal committees are standing advisory committees of NICE. This topic was considered by committee B. Committee members are asked to declare any interests in the vadadustat being ...
National Institute for Health and Care Excellence8d
Niraparib with abiraterone acetate and prednisone for untreated hormone-relapsed metastatic prostate cancer (terminated appraisal)
NICE is unable to make a recommendation about the use in the NHS of niraparib (Zejula) with abiraterone acetate and prednisone for untreated hormone-relapsed metastatic prostate cancer in adults. This ...